About NEBION
NEBION is a Healthcare company based in Zurich (Switzerland) founded in 2008, and was acquired by Immunai in July 2021. Software and services for biomarker and target discovery are provided. It operates on a SaaS (Software-as-a-Service) model. NEBION offers products and services including GENEVESTIGATOR. Its focus areas include Biotechnology and Pharmatech. Its legal entity is Immunai / NEBION AG.
Company details
NEBION, now part of Immunai, is focused on supporting artificial intelligence with high-quality transcriptome data. The company, operating in the pharmatech sector, offers GENEVESTIGATOR, a platform used by researchers for discoveries in academia and industry. Immunai, the parent entity, structures vast datasets of samples and cells under a unified clinical ontology, enhanced by expert curation. Solutions are provided to advance drug development and research through innovative data platforms.
- Headquarters Zurich, Switzerland
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website nebion.com
- Social LinkedIn X
- Acquired by Immunai (Jul 2021)
- Legal Name Immunai / Nebion Ag
- Latest Funding Round$9.83K (USD), Grant
Jun 2007
- InvestorsImmunai Technologies
& 1 more
- Acquired byImmunai
(Jul 2021)
Products & Services of NEBION
NEBION offers a comprehensive portfolio of products and services, including GENEVESTIGATOR.
A platform for advanced research discoveries is provided.
Funding Insights of NEBION
- Total Rounds 1
- Last Round Grant — $9,825
- First Round $9,825
(Jun 2007)
- Investors Count 1
All 1 funding rounds of NEBION with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2007 | $9,825 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in NEBION
NEBION has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Immunai Technologies and Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
University backed startup accelerator | venturekick.ch | Schlieren, Switzerland | ||
Next-generation immunomodulatory therapeutics are developed using multi-omic analysis. | 2018 | immunai.com | United States |
Investor details for NEBION
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NEBION
3 dated milestones of NEBION across 14 years, from founding to its latest funding, stage changes and deals.
- Funding First funding round of $10K.
- Founded NEBION is founded.
- Exit Acquired by Immunai.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nebion
Complete news archive for NEBION
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NEBION
NEBION was founded in 2008.
NEBION is headquartered in Zurich, Switzerland.
NEBION, now part of Immunai, is focused on supporting artificial intelligence with high-quality transcriptome data. The company, operating in the pharmatech sector, offers GENEVESTIGATOR, a platform used by researchers for discoveries in academia and industry. Immunai, the parent entity, structures vast datasets of samples and cells under a unified clinical ontology, enhanced by expert curation. Solutions are provided to advance drug development and research through innovative data platforms.
NEBION offers GENEVESTIGATOR.
NEBION has 2 investors. Key investors include Immunai Technologies, and Venture Kick.
NEBION operates through Immunai / Nebion Ag.
Yes. NEBION was acquired by Immunai in July 2021.